Related by context. All words. (Click for frequent words.) 72 Adjuvant chemotherapy 72 β blockers 72 colorectal adenoma 71 mutated K ras 71 prophylactic cranial irradiation 71 pCR 71 corticosteroid therapy 70 HIV HCV coinfected 70 neutropenic patients 70 primary aldosteronism 70 imatinib resistance 70 endometrial hyperplasia 70 pyridostigmine 70 liver metastasis 70 ß blockers 70 paricalcitol 70 elevated LDH 69 nonmelanoma skin cancers 69 prostate cancer CaP 69 histological subtype 69 hematopoietic cancers 69 baseline LDH 69 radioiodine therapy 69 urothelial cancer 69 carotid stenosis 69 mitochondrial toxicity 69 androgen deprivation 69 acromegalic patients 69 CsA 69 postoperative AF 69 perioperative complications 69 Candida infection 68 Heavy menstrual bleeding 68 pancreatic adenocarcinoma 68 trans retinoic acid 68 immunosuppressive medications 68 pelvic lymphadenectomy 68 T1DM 68 HbF 68 thrombotic complications 68 adrenal function 68 thrombocytopenic 68 leiomyomas 68 polyp recurrence 68 K ras mutations 68 SSc 68 colorectal liver metastases 68 noncardiac 68 aromatase inhibitor therapy 68 teratogens 68 RAS blockers 68 somatostatin analogs 68 decompensated cirrhosis 68 flutamide 68 metaplasia 68 bladder carcinoma 68 pentoxifylline 68 haematologic 68 renal cell carcinomas 68 basal cell nevus syndrome 68 microvascular dysfunction 68 thrombocytosis 67 amenorrhoea 67 anticonvulsant medications 67 antiandrogens 67 Hurthle cell 67 prostate carcinoma 67 MGUS 67 beta blocker therapy 67 testicular tumors 67 intact parathyroid hormone 67 GnRH agonists 67 intravenous bisphosphonates 67 recurrent glioblastoma multiforme 67 erythropoietic 67 TMP SMX 67 abdominal irradiation 67 surgical debulking 67 clinically insignificant 67 ALI ARDS 67 antithrombotic therapy 67 overt hypothyroidism 67 HSCT 67 lichen planus 67 radiochemotherapy 67 euthyroid 67 nonalcoholic steatohepatitis NASH 67 cranial radiation 67 ALND 67 dexrazoxane 67 nephrotoxicity 67 cisplatin resistant 67 histologic subtype 67 osteosarcomas 67 postoperative complication 67 conventional DMARDs 67 neoplasias 67 androgen ablation 67 genotypic resistance 67 chemoradiation therapy 67 pretransplant 67 BEXXAR Therapeutic Regimen 67 hepatorenal syndrome 67 stratifying patients 67 NPH insulin 67 orchitis 67 octreotide LAR 67 postoperative morbidity 67 antiarrhythmic medications 67 renal allograft 66 mycophenolate 66 hematologic parameters 66 abacavir Ziagen 66 perioperatively 66 thyrotropin 66 antioxidant supplementation 66 gastric cardia 66 mycophenolate mofetil MMF 66 relapsed MM 66 adriamycin 66 prostate adenocarcinoma 66 cerebral vasospasm 66 biochemical abnormalities 66 psychiatric comorbidity 66 neurodevelopmental impairment 66 G6PD deficiency 66 intracranial hemorrhage ICH 66 cutaneous melanoma 66 breast endometrial 66 GSTT1 66 eosinophil count 66 adrenalectomy 66 histologically proven 66 unresectable tumors 66 malabsorptive 66 Radiofrequency ablation 66 imipenem 66 oral anticoagulation 66 hypercalciuria 66 HPA axis suppression 66 fructose intolerance 66 immunopathology 66 debulking surgery 66 antibiotic prophylaxis 66 intestinal polyps 66 bronchoalveolar 66 rFVIIa 66 liver histology 66 operable breast cancer 66 systemic corticosteroids 66 hamartomas 66 NNRTI resistance 66 Calcium intake 66 colorectal carcinoma 66 Surgical resection 66 vWF 66 LV dysfunction 66 deletion 5q 66 thymectomy 66 antimicrobial prophylaxis 66 basal cell carcinoma BCC 66 hemodilution 66 PSA nadir 66 benign uterine 66 thiopurine 66 recurrent UTI 66 hepatic encephalopathy HE 66 elevated triglyceride levels 66 acute respiratory tract infections 66 IOP lowering 66 intracranial stenosis 66 gastric adenocarcinoma 66 axillary node dissection 66 SGPT 66 severe exacerbations 66 dysfunctional voiding 66 radioimmunotherapy RIT 66 attain statistical significance 66 anthracycline chemotherapy 66 GIST tumors 66 conjugated estrogen 66 Cognitive impairment 66 carotid plaque 66 adjuvant radiotherapy 66 cervical lymph nodes 66 metastatic lymph nodes 66 Leydig cell 66 CR nPR 66 TT genotype 66 deferoxamine 66 surgically resectable 66 preoperative chemotherapy 66 angiographically 66 antiplatelet medications 65 anticholinergic agents 65 transaminase elevations 65 Adjuvant therapy 65 HER2 expression 65 platelet reactivity 65 macrovascular events 65 transferrin saturation 65 antibiotic regimens 65 underactive thyroids 65 chorioamnionitis 65 nephrotoxic 65 CP CPPS 65 EBV infection 65 chlorthalidone 65 glucocorticoid therapy 65 immunosuppressive regimen 65 relapsed ALL 65 postoperative infections 65 acute lymphoid leukemia 65 BPS IC 65 trastuzumab Herceptin ® 65 Combination therapy 65 chlamydial infection 65 systemic corticosteroid 65 nonischemic 65 serum urate levels 65 cystic lesions 65 Toxicities 65 fetal malformations 65 sotalol 65 serum calcium levels 65 perioperative morbidity 65 endometrial carcinoma 65 adnexal mass 65 complete cytogenetic response 65 posttransplant 65 anemia hemoglobin 65 symptomatic intracranial hemorrhage 65 HBeAg negative 65 hepatic cirrhosis 65 cytoreduction 65 ovarian malignancy 65 hepatic toxicity 65 CMV infection 65 caspofungin 65 impair fertility 65 curative therapy 65 Kinoid 65 aminotransferase levels 65 autonomic dysfunction 65 tumor subtype 65 myelosuppressive 65 postoperative chemotherapy 65 oral anticoagulant therapy 65 RAS mutations 65 TNF antagonist 65 CYP#D# inhibitor 65 chemosensitivity 65 biochemical relapse 65 idiopathic PAH 65 fulvestrant 65 pulmonary resection 65 cystic fibrosis chronic pancreatitis 65 allogeneic hematopoietic stem cell 65 albumin excretion 65 conventional angiography 65 oesophageal adenocarcinoma 65 artery stenosis 65 contrast induced nephropathy 65 recurrent venous thromboembolism 65 leukocyte count 65 neurologic deficits 65 mesalamine granules 65 ECD kidneys 65 arterial calcification 65 lenalidomide dexamethasone 65 renoprotective 65 squamous cell lung cancer 65 NMDA antagonists 65 carotid IMT 65 ocular toxicity 65 allogeneic transplant 65 uridine triacetate 65 pleiotropic effects 65 perioperative mortality 65 nondiabetic patients 65 ADPKD 65 lymphocyte counts 65 CTEPH 65 antidiabetic drugs 65 solar keratoses 65 antihypertensive therapy 65 Doxil ® 65 primary hyperparathyroidism 65 skeletal metastases 65 renal tumors 65 clinicopathological 65 IV bisphosphonates 65 atherothrombotic 65 pulmonary dysfunction 65 tryptase 65 hypercoagulable 65 cisplatin chemotherapy 65 Genetic predisposition 65 epithelial tumors 65 normal karyotype 65 motor neuron degeneration 65 malignant neoplasm 65 idarubicin 65 polytherapy 65 spinal metastases 65 LVRS 65 uterine tumors 65 alanine aminotransferase ALT 65 saline infusion 65 plasminogen activators 65 ANCA associated 65 adenomatous polyps 65 cryptogenic 65 liver transplant recipients 65 invasive carcinoma 65 rebleeding 65 hyperalgesia 65 bleomycin 65 CYP #D# 65 pT2 65 antiemetics 65 Chronic pancreatitis 65 antiarrhythmic drugs 65 hemorrhagic complications 65 glycated hemoglobin levels 65 histopathologic examination 65 hepatocellular carcinomas 65 cardiotoxic 65 oxcarbazepine 65 Mitomycin C 65 hypericin 65 Legg Calvé Perthes disease 65 antibody titer 65 androgen suppression 65 portal vein thrombosis 65 B7 H3 65 COPD exacerbations 65 underlying pathophysiology 65 E. faecalis 65 histologically confirmed 65 antidiabetic medication 65 antihypertensive medication 65 untreated celiac disease 65 shorter telomere length 65 pulmonary toxicity 65 systemic toxicity 65 thrombotic events 65 methotrexate monotherapy 65 extrapyramidal symptoms 65 antiplatelet therapies 65 pamidronate 65 renal scarring 65 acute lymphoblastic 65 radical nephrectomy 65 tamoxifen Nolvadex ® 65 antiproliferative effects 65 pelvic irradiation 65 oncologic outcomes 65 vesicoureteral reflux 64 diabetic polyneuropathy 64 immunodeficient 64 peritoneal carcinomatosis 64 bronchoalveolar lavage BAL 64 rhTSH 64 Helicobacter pylori infection 64 busulfan 64 imatinib Gleevec 64 EXJADE 64 nodal metastases 64 myocardial dysfunction 64 immunocompetent 64 thyroid carcinoma 64 standard chemotherapy regimens 64 neurologic complications 64 tumor histology 64 GISTs 64 external beam radiotherapy 64 thromboprophylaxis 64 ABCB1 64 abnormal Pap smears 64 antiandrogen 64 antiphospholipid antibodies 64 glomerular filtration 64 peritoneal cancer 64 paroxysmal AF 64 seropositivity 64 HBeAg 64 poor metabolizers 64 urothelial carcinoma 64 adenoidectomy 64 salmeterol fluticasone 64 torsade de pointes 64 vaginal hysterectomy 64 thromboembolic events 64 aldosterone antagonist 64 amyloid deposition 64 EBRT 64 nonpharmacologic 64 AChE inhibitors 64 prognostic indicators 64 bacterial prostatitis 64 immunosuppressive therapies 64 H. pylori eradication 64 precursor lesions 64 salivary flow 64 myeloablative 64 serum creatinine levels 64 CIN3 64 CC genotype 64 colorectal neoplasms 64 antiangiogenic therapy 64 hyperoxaluria 64 neurologic sequelae 64 thalidomide Thalomid 64 fibrinolysis 64 chemoresistant 64 incidentalomas 64 d4T stavudine Zerit 64 colorectal tumor 64 steatohepatitis 64 SIADH 64 spontaneous regression 64 Liver transplantation 64 NMIBC 64 blood glucose concentrations 64 daily subcutaneous injections 64 Postoperative complications 64 atypical antipsychotic medications 64 p# mutations 64 EGFRIs 64 estrogen estradiol 64 pneumonectomy 64 mycophenolate mofetil 64 transaminase levels 64 % CI #.#-#.# [007] 64 hematologic toxicity 64 microsatellite instability 64 antithyroid 64 systolic dysfunction 64 allogeneic HSCT 64 antiplatelet drugs 64 trans retinoic acid ATRA 64 IPAH 64 endothelial activation 64 timepoints 64 sarcomatoid 64 pharmacologic treatments 64 myocardial fibrosis 64 bezafibrate 64 locoregional recurrence 64 fluvastatin 64 atypical neuroleptics 64 chest radiographs 64 fibrate drugs 64 intracerebral haemorrhage 64 GSTM1 gene 64 serous ovarian cancer 64 gastrointestinal stromal tumors GISTs 64 Bosentan 64 undergoing CABG 64 de novo AML 64 thrombophilia 64 APTIVUS r 64 euthymic patients 64 transfusion syndrome 64 coagulation abnormalities 64 nonvascular 64 Barrett esophagus BE 64 urolithiasis 64 reinfarction 64 chlamydial 64 selenium supplementation 64 clomipramine 64 virological response 64 concomitant medications 64 mycosis fungoides 64 abacavir lamivudine 64 serum TSH 64 acetylcysteine 64 LNG IUS 64 neovascularisation 64 TPMT 64 nicardipine 64 Flu Cy 64 coronary calcification 64 neutrophil counts 64 transgene expression 64 colorectal adenocarcinoma 64 hypoperfusion 64 Cytoxan 64 tibolone 64 invasive candidiasis 64 noncancer 64 hepatic fibrosis 64 carcinoid tumor 64 sulfasalazine 64 pyridoxine 64 nasal polyposis 64 prostate cancer PCa 64 immunosuppression therapy 64 adverse cytogenetics 64 Chronic lymphocytic leukemia 64 malignant lymphomas 64 TNF alpha antagonist 64 amifostine 64 antiepileptic medications 64 radiotherapy RT 64 ximelagatran 64 papillary renal cell carcinoma 64 benign nodules 64 basal cell cancers 64 ovulatory cycles 64 labetalol 64 advanced adenomas 64 Cardiotoxicity 64 perfusion abnormalities 64 multivariate analyzes 64 preoperative PSA 64 canakinumab 64 endoxifen 64 cellularity 64 ablative therapy 64 GH deficiency 64 Radical prostatectomy 64 idiopathic pulmonary 64 chemoembolization 64 Severe Primary IGFD 64 ergot alkaloids 64 AST ALT 64 neurocognitive deficits 64 serum BDNF 64 precancerous condition 64 aortic root replacement 64 hormone receptor negative 64 comorbid disorders 64 ovarian carcinoma 64 MMSE score 64 silibinin 64 lumbar disk herniation 64 lipid lowering therapies 64 olmesartan 64 antithymocyte globulin 64 coagulopathy 64 beta carotene supplementation 64 PSADT 64 thiazide 64 indinavir 64 mGluR5 antagonist 64 serum lipid levels 64 postoperative hemorrhage 64 Sjögren syndrome 64 protease inhibitor PI 64 nonfasting triglyceride levels 64 malignant growths 64 exocrine pancreas 64 5-fluorouracil/leucovorin 64 quetiapine Seroquel 64 Elevated serum 64 reflux symptoms 64 prolactin levels 64 % CI #.#-#.# [008] 64 probiotic supplementation 64 androgen suppression therapy 64 postoperative mortality 64 proliferative diabetic retinopathy 64 chronic GVHD 64 neurocognitive function 64 CVD mortality 64 metastatic malignant melanoma 64 grade gliomas 64 hMG 63 coinfected patients 63 nodal metastasis 63 confounding variables 63 anthracycline therapy 63 Genetic variants 63 iron chelators 63 leukocyte counts 63 etiologic 63 chemopreventive agents 63 adrenocorticotropic hormone 63 seminomas 63 de ath 63 anticoagulants blood thinners 63 candidemia 63 gadobutrol 63 adenoma recurrence 63 inhaled bronchodilators 63 liver scarring 63 anti angiogenic agents 63 hypoglycemic episodes 63 breast carcinoma 63 neoplastic 63 CYP #A# 63 griseofulvin 63 CCyR 63 sacral neuromodulation 63 ALT elevations 63 adrenal suppression 63 invasive ductal breast cancer 63 preterm neonates 63 extramedullary 63 adjuvant therapies 63 neuroleptics 63 lipid lowering agents 63 hypercalcaemia 63 hereditary predisposition 63 Basal Cell 63 prognostic indicator 63 Alequel 63 ovarian hormones 63 cytoreductive surgery 63 ductal cancer 63 C1 INH deficiency 63 invasive fungal infection 63 fulminant hepatic failure 63 B Cell Lymphoma 63 oncological outcomes 63 induce orthostatic hypotension 63 scintigraphic 63 NNT = 63 epithelial barrier 63 nitrofurantoin 63 μmol L 63 DMARDS 63 curative resection 63 adenomatous 63 bacteriuria 63 asymptomatic carotid stenosis 63 vestibular schwannomas 63 retransplantation 63 venous thromboembolic disease 63 neuroblastoma tumors 63 neurologic progression 63 folinic acid 63 metastatic uveal melanoma 63 multivariable adjusted 63 liposomal amphotericin B 63 overactive bladder symptoms 63 GBA mutations 63 serum PTH 63 imatinib therapy 63 brain lesions 63 multivariable analysis 63 acute GvHD 63 pulmonary metastases 63 immunosuppressant therapy 63 postoperative pulmonary 63 relapsed SCLC 63 bone marrow suppression 63 axillary dissection 63 metastatic neuroendocrine tumors 63 intravenous cyclophosphamide 63 clinicopathological features 63 undergoing peritoneal dialysis 63 immune modulating 63 revascularization procedures 63 gastric carcinoma 63 elevated ALT 63 colorectal tumors 63 postprandial glycemia 63 plasma folate 63 tricyclic antidepressant 63 thyroid deficiency 63 lymphadenectomy 63 HNSCC 63 anastomotic leak 63 atrophic gastritis 63 lipid abnormalities 63 bronchogenic carcinoma 63 axillary lymph nodes 63 astrocytomas 63 rhGH 63 Nonspecific 63 autoantibody levels 63 anthracycline containing 63 adjunctive placebo 63 T2DM 63 Hurler syndrome 63 stone formers 63 neuroleptic 63 atorvastatin #mg 63 systemic amyloidosis 63 antireflux surgery 63 Non inferiority 63 Nicotine dependence 63 therapeutic regimens 63 carotid artery blockage 63 rHuEPO 63 cefazolin 63 corticosteroid dose 63 macrolide antibiotic 63 mucosal inflammation 63 thromboembolic disease 63 Parnate 63 prothrombotic 63 papillomas 63 familial clustering 63 chronic prostatitis 63 allogeneic transplantation 63 thyroglobulin 63 Papillary 63 malignant lymphoma 63 renal toxicity 63 surrogate markers 63 gadolinium enhanced 63 nondemented 63 symptomatic VTE 63 tumor regressions 63 leptin deficiency 63 F FDG PET 63 endometrial biopsies 63 differential gene expression 63 mutated KRAS gene 63 IGFBP 3 63 Hormonal therapy 63 clinically detectable 63 vasopressor 63 mesotheliomas 63 unconjugated 63 interferon alfa 2b 63 tumor necrosis 63 hypercholesterolaemia 63 anagrelide 63 p# activation 63 neutropaenia 63 lymph node dissection 63 N. gonorrhoeae 63 plasma renin activity 63 Venous thromboembolism 63 azacytidine 63 Decitabine 63 thyroid stimulating hormone 63 CYP#A# inhibitors 63 dosing frequency 63 paclitaxel eluting stents 63 intravesical therapy 63 bilateral oophorectomy 63 DHEA supplementation 63 Leukemias 63 univariate analyzes 63 azacitidine 63 elevated transaminases 63 ALA PDT 63 SLNB 63 thrombocytopenic patients 63 SHBG levels 63 myopathy rhabdomyolysis 63 HGPIN 63 hyperplastic polyps 63 digoxin toxicity 63 invasive aspergillosis 63 T1c 63 bullous 63 Hematologic 63 grade cervical intraepithelial 63 bacteremic 63 alkylating agent 63 potassium sparing diuretics 63 KRAS status 63 IFN beta 63 Pegylated Interferon 63 serum selenium 63 conjugated equine estrogen 63 serum phosphate 63 pleurodesis 63 bronchoalveolar lavage fluid 63 antitumor effect 63 PCNSL 63 aminotransferase 63 MYCN amplification 63 triglyceride concentrations 63 hepatoma 63 thyrotropin levels 63 adjuvant cisplatin 63 elevated CRP 63 platelet inhibitor 63 Capecitabine 63 plasma pharmacokinetics 63 Radiofrequency Ablation RFA 63 homocysteine concentrations 63 graft occlusion 63 eculizumab therapy 63 orchiectomy 63 isoproterenol 63 percutaneous drainage 63 serum aminotransferase levels 63 platelet dysfunction 63 endoscopic ultrasonography 63 amoxicillin clavulanate 63 serum uric acid 63 subependymal giant cell 63 thromboembolism 63 metastatic malignant 63 APOE genotype 63 pulmonary hypertension PH 63 Lung transplantation 63 ductal breast cancer 63 riociguat 63 DFMO 63 chemotherapeutic regimens 63 serum parathyroid hormone 63 hyperplastic 63 hormone receptor status 63 completely resected 63 Randomized trials 63 advanced adenoma 63 nonmetastatic 63 dopaminergic therapy 63 fluticasone salmeterol 63 concomitant AEDs 63 bone scintigraphy 63 GP IIb IIIa inhibitors 63 nonadherence 63 FDG PET imaging 63 hypoglycaemic episodes 63 undergoing liver transplantation 63 empiric treatment 63 serum concentrations 63 myocardial reperfusion 63 atypical hemolytic uremic syndrome 63 endocrine therapies 63 abdominal adiposity 63 oral hypoglycemic agents 63 hepatocellular 63 TNF α 63 receptor blocker 63 lactate dehydrogenase 63 intensive statin therapy 63 anticoagulant warfarin 63 somatization disorder 63 invasive carcinomas 63 multimodality therapy 63 #F FDG PET 63 antitumor efficacy 63 TNF blocker therapy 63 BENICAR HCT 63 Subgroup analysis 63 treating neuropathic pain 63 nephron sparing surgery 63 p = #.# [003] 63 aromatase inhibitors AIs 63 epidural steroid injection 63 HER2 amplification 63 secondary amenorrhea 63 HbA 1c levels 63 dalteparin 63 Gliadel Wafer 63 DMSA 63 mild renal insufficiency 63 oral clodronate 63 juvenile idiopathic arthritis JIA 63 allogeneic SCT 63 varices 63 OGG1 63 noncardiovascular mortality 63 indolent lymphomas 63 antiphospholipid syndrome 63 pediatric acute lymphoblastic 63 lung resection 63 Chronic Prostatitis 63 antiepileptics 63 gastrointestinal GI bleeding 63 Pemetrexed 63 p tau 63 hyperphenylalaninemia HPA due 63 tumoral 62 bowel resection 62 neurocognitive impairment 62 ATACAND 62 acarbose 62 fluid overload 62 serum phosphate levels 62 alteplase 62 cardiac dysfunction 62 triiodothyronine 62 lobular breast cancer 62 renal cysts 62 elevated IOP 62 hypertonic saline 62 biologic plausibility 62 neurologic impairment 62 Candida infections 62 von Willebrand 62 dosage regimens 62 immunosuppressive agents 62 type 1diabetes 62 follicular thyroid cancer 62 Relapsing remitting MS 62 pancreatectomy 62 malignant neoplasms 62 squamous cell carcinoma SCC 62 AZT zidovudine Retrovir 62 tHcy 62 pressor response 62 hepatotoxic 62 CLA supplementation 62 palifermin 62 epididymitis 62 SCIg 62 predisposing factor 62 microdose 62 colorectal cancer liver metastases 62 ubiquinol 62 dose Iluvien 62 leukaemias 62 reoperations 62 triacylglycerol concentrations 62 cis retinoic acid 62 hyperinsulinism 62 ACE Inhibitors 62 Fas ligand 62 Plaquenil 62 Eisenmenger syndrome 62 thiazides 62 elevated creatinine 62 daunorubicin 62 nutlin 3a 62 lupus anticoagulant 62 5-FU/LV 62 depressive symptomatology 62 valvular heart disease 62 thyroxine 62 chronic urticaria 62 FXIII 62 follicular lymphoma FL 62 moderately emetogenic 62 prednisone prednisolone 62 neutropenic 62 HBeAg seroconversion 62 radical prostatectomy RP 62 hydroxychloroquine 62 serum testosterone levels 62 lymphoproliferative disorders 62 pyrazinamide 62 inflammatory biomarkers 62 metachronous 62 paraganglioma 62 extracapsular extension 62 angiosarcoma 62 upper gastrointestinal bleeding 62 statin medications 62 trimethoprim sulfamethoxazole 62 H pylori 62 ALT flares 62 parathyroid 62 everolimus eluting stents 62 sorafenib Nexavar 62 myeloproliferative diseases 62 familial pancreatic cancer 62 serum IGF 62 endometrial thickness 62 cardiac repolarization 62 VUR 62 chromosomal mutations 62 RBC transfusions 62 Valproate 62 mitomycin C 62 VaD 62 node metastases 62 thromboembolic complications 62 monoclonal gammopathy 62 hemodialysis patients 62 thyroid nodules 62 fructose intolerant 62 cancerdefine 62 VP# [004] 62 Glioblastoma Multiforme GBM 62 LVNC 62 hepatectomy 62 platelet inhibition 62 lymphomas leukemias 62 penetrance 62 thromboembolic 62 neurodevelopmental outcomes 62 radiosensitivity 62 chronic rhinosinusitis 62 cirrhotic patients 62 aldosterone antagonists 62 Glucocorticoids 62 antiangiogenic agent 62 coronary blockages 62 airway responsiveness 62 carcinomatosis 62 Pseudomonas aeruginosa infections 62 renal dysfunction 62 cytotoxic chemotherapy 62 cervical lesions 62 nonvertebral fracture 62 testosterone supplementation 62 leukoencephalopathy 62 psychosocial variables 62 total thyroidectomy 62 cervical carcinoma 62 hamartoma 62 cerebral infarction 62 Oral corticosteroids 62 Febrile neutropenia 62 neoadjuvant treatment